|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 254 IDR | 0.00% |
|
-18.06% | +3.25% |
PT Diagnos Laboratorium Utama Tbk reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was IDR 96,855.98 million compared to IDR 168,789.32 million a year ago. Net income was IDR 10,427.97 million compared to IDR 46,092.04 million a year ago.
Basic earnings per share from continuing operations was IDR 8.34 compared to IDR 36.87 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.25% | 1.99Cr | |
| -16.58% | 867.4Cr | |
| +65.60% | 425.4Cr | |
| -9.46% | 247.01Cr | |
| -1.12% | 250.87Cr | |
| -44.11% | 225.14Cr | |
| -7.42% | 191.44Cr | |
| -18.68% | 155.97Cr | |
| -41.75% | 119.01Cr | |
| +11.31% | 114.62Cr |
PT DIAGNOS LABORATORIUM UTAMA TBK 
